Special Protein Unit
Special Protein Unit
The Special Protein Unit serves as a reference laboratory for specialised protein diagnostic services. It conducts advanced and high-tech biomedical research and development (R&D), including new laboratory methods and biomarker discovery. It provides various training programs in specialised protein diagnostics for researchers and officers from within and outside IMR, as well as for students from local and international higher education institutions. The unit also offers consultancy services in specialised protein diagnostics to researchers, officers, and students from both within and outside IMR.
Executive Summary
Head of Special Protein Unit
Dr. Noor Hafizah Binti Hassan
MD (USM, Malaysia), Doctor of Pathology (Chemical Pathology) (UKM, Malaysia)
Telephone: +603-2616 2781
Email: hafizahh@moh.gov.my
Human Resource Profile
Specialist
Medical Officers
Science Officer
Support Staffs
Focus Area
Discovery, Investigation and Diagnostics, Treatment and Management, Prevention, Prediction
Scope: Rare genetic diseases
Highlights
Identification of biomarkers
Test method development, evaluation and validation
Metabolomics - Test method development, evaluation and validation
Population-based screening and epidemiology
Bioinformatics
Special Protein Diagnostics
Expert in providing consultation, data interpretation, and advisory support to ensure high-quality outcomes in amino acid disorders and special protein disorders in diagnosis and management.
Area of Expertise
Immunonephelometry techniques
HPLC
Capillary electrophoresis
Special Protein Research
Expert guidance on special protein disorders research methodology, study design, and protocol development.
Area of Expertise
Amino acid disorders profiling, characterisation, and standardisation including immunonephelometry, HPLC and capillary electrophoresis
Special protein disorders including Alpha 1 antitrypsin phenotyping and transferrin isoforms
Bioinformatics data analysis of computational proteomics datasets to identify disease-causing variants, pathways, and potential therapeutic targets